Le Lézard
Classified in: Health, Science and technology
Subjects: TDS, FVT

Diode Laser Collimation & Beam Shaping Optics to be Exhibited by FISBA at LASER World of PHOTONICS CHINA


ST GALLEN, Switzerland, Feb. 21, 2018 /PRNewswire/ -- FISBA, a world leader in optical components and systems, will exhibit at LASER World of PHOTONICS CHINA Booth 4122, March 14-16, 2018 in Shanghai, China.  FISBA designs and manufactures custom micro optics for laser diodes, which include FACs, SACs, and FBTs.

Customized Optical Components for Diode Laser Collimation & Beam Shaping.

In order for diode lasers to reach their full potential, output beams must be shaped to optimize optical quality. FISBA's components enable this precise collimation and beam shaping. FACs collimate the beam in the fast axis, but to fully collimate the diode output beam, they should be combined with other micro optical components. FISBA offers acircular cylindric Slow Axis Collimators (SACs) for single emitters, SAC arrays for multi-emitters, and preassembled components, like the FISBA Beam Twistertm.

FISBA offers a large portfolio of standard lenses for diode laser collimation and beam shaping, as well as custom solutions tailored to customers' application-specific needs.  Learn more by visiting FISBA at LASER World of PHOTONICS CHINA.

About FISBA
FISBA is a worldwide leading supplier of customized optical components and systems for Life Sciences, Production Technology and Defense & Security applications. For over 60 years, it has been a company priority to stay progressive without losing sight of FISBA's founding values. This mindset has enabled FISBA to become one of the most innovative suppliers in the optics industry, as well as a trusted partner to customers. FISBA operates at locations in Switzerland, Germany and the USA.

Media Contact
Birgit Rauch
Head of Corporate Marketing Communication
[email protected]
www.fisba.com

 

FISBA Logo

SOURCE FISBA


These press releases may also interest you

at 21:59
Innovent to Present Clinical Data of Multiple Novel Molecules at the 2024 ASCO Annual Meeting
Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of oncology, cardiovascular and metabolic, autoimmune, ophthalmology...

at 21:27
Labcorp Announces Winning Bid for Select Assets of Invitae
Labcorp , a global leader of innovative and comprehensive laboratory services, announced today that it has been selected as the winning bidder for select assets of Invitae, a leading medical genetics company.  Before the transaction can proceed,...

at 21:19
Invitae Enters into Agreement with Labcorp for Sale of Business
Invitae , a leading medical genetics company, announced that Labcorp , a global leader of innovative and comprehensive laboratory services, has been selected...

at 21:05
/C O R R E C T I O N -- Valcare Medical/
Valcare Medical, Inc., a leading innovator in transcatheter-based mitral...

at 21:02
ASCO 2024 | Ascentage Pharma to Present Four Studies, Including an Oral Report Featuring the Latest Data of Olverembatinib in SDH-Deficient GIST
Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in developing novel therapies for cancer, chronic hepatitis B (CHB), and age-related diseases, announced today that results from four clinical studies of the company's three key...

at 19:59
Genomma Lab Internacional Announces Results for the First Quarter 2024
Genomma Lab Internacional, S.A.B. de C.V. (BMV: LAB B) ("Genomma" or "the Company"), today announced its results for the first quarter of 2024. All figures included herein are stated in nominal Mexican pesos and have been prepared in accordance with...

More news about Health...


News published on and distributed by: